Dr. David Kerr reports on a provocative phase 2 trial in quadruple wild-type colorectal cancer and surmises that CRC may be catching up with lung cancer as a disease increasingly defined by genotype.

Dr. Mark Kris presents some hard facts about the incidence of lung cancer among nonsmokers and the importance of adjusting our attitudes toward lung cancer patients.

George Lundberg talks about the RUC -- how its structure and evolution have harmed healthcare, and the necessity of changing it.

Mississippi passed a law enabling the use of cord blood to identify older men who had sex with underage girls. Is it ethical for doctors to comply with this?

Many doctors consider mandatory drug testing for health professionals an insult, but if we're going to improve quality of patient care, it makes sense, says bioethicist Art Caplan.

Michael Jaff talks about the care redesign program from the Mass General Institute for Heart, Vascular and Stroke Care, and how it will improve care and cut cost.

The results of a recent pooled analysis by Dr. Harry Buller, although counterintuitive, indicate the relative safety of full-dose rivaroxaban vs standard anticoagulation for these patients.

Dr. George Lundberg returns to Medscape with a commentary on the AMA's new policy statement that obesity is a disease.

Sandra Fryhofer discusses the new blueprint from ASCO for managing cancer survivor patients.

Is the nation on the verge of a healthcare provider shortage, or are clinicians being phased out by algorithms?